OK I'll give you that, but I'm not the only investor that would call ACTC a gamble.
"Investing" in a company with little track record and no product meets the definition of gambling too!
What percentage of potential new drugs go to clinical trial only to show no statistical benefit over the placebo? Maybe we have a great treatment for humans or maybe it only works in mice. The hamster world will be ablaze but not share price.
This is not like investing in a big pharma that has current product with other potential products in the pipeline.
Don't kid yourself -- it's a gamble but it's one I'm willing to take!